American Society of Clinical Oncology (ASCO), May 2015

A final report of pediatric Phase I clinical trial of p28 will be presented at the 2015 meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL.

Title: Phase 1 Trial of p28 (NSC745104), a Non-HDM2 Mediated Peptide Inhibitor of p53 Ubiquitination in Children with Recurrent or Progressive CNS Tumors: A Final Report from the Pediatric Brain Tumor Consortium. Abstract # 10059

http://abstracts.asco.org/156/AbstView_156_152030.html